Publication details

Cyanotoxin cylindrospermopsin disrupts lipid homeostasis and metabolism in a 3D in vitro model of the human liver

Investor logo
Investor logo
Investor logo
Authors

ROY CHOWDHURY Riju FELIPE GROSSO Marina GADARA Darshak Chandulal SPÁČIL Zdeněk VIDOVÁ Veronika SOVADINOVÁ Iva BABICA Pavel

Year of publication 2024
Type Article in Periodical
Magazine / Source Chemico-Biological Interactions
MU Faculty or unit

Faculty of Science

Citation
web https://www.sciencedirect.com/science/article/pii/S0009279724001923?via%3Dihub
Doi http://dx.doi.org/10.1016/j.cbi.2024.111046
Keywords Harmful cyanobacterial blooms; Hepatospheroids; LC-MS-Based lipid profiling; Non-alcoholic fatty liver disease; NAFLD; Metabolic dysfunction-associated fatty liver; disease; MAFLD
Attached files
Description Cylindrospermopsin, a potent hepatotoxin produced by harmful cyanobacterial blooms, poses environmental and human health concerns. We used a 3D human liver in vitro model based on spheroids of HepG2 cells, in combination with molecular and biochemical assays, automated imaging, targeted LC-MS-based proteomics, and lipidomics, to explore cylindrospermopsin effects on lipid metabolism and the processes implicated in hepatic steatosis. Cylindrospermopsin (1 mu M, 48 h) did not significantly affect cell viability but partially reduced albumin secretion. However, it increased neutral lipid accumulation in HepG2 spheroids while decreasing phospholipid levels. Simultaneously, cylindrospermopsin upregulated genes for lipogenesis regulation (SREBF1) and triacylglycerol synthesis (DGAT1/2) and downregulated genes for fatty acid synthesis (ACLY, ACCA, FASN, SCD1). Fatty acid uptake, oxidation, and lipid efflux genes were not significantly affected. Targeted proteomics revealed increased levels of perilipin 2 (adipophilin), a major hepatocyte lipid droplet-associated protein. Lipid profiling quantified 246 lipid species in the spheroids, with 28 significantly enriched and 15 downregulated by cylindrospermopsin. Upregulated species included neutral lipids, sphingolipids (e.g., ceramides and dihexosylceramides), and some glycerophospholipids (phosphatidylethanolamines, phosphatidylserines), while phosphatidylcholines and phosphatidylinositols were mostly reduced. It suggests that cylindrospermopsin exposures might contribute to developing and progressing towards hepatic steatosis or metabolic dysfunctionassociated steatotic liver disease (MASLD).
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info